Skip to search boxSkip to navigationSkip to main content

Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers

  • Cristina Domingo(corresponding author)
    ,
  • Fernando de Ory
    ,
  • Juan Carlos Sanz
    ,
  • Noelia Reyes
    ,
  • Joaquim Gascón
    ,
  • Ole Wichmann
*Corresponding author for this work
  • Instituto de Salud Carlos III
    ,
  • Regional Public Health Laboratory of the Madrid County
    ,
  • Hospital Clinic Barcelona
    ,
  • Charité Universitätsmedizin Berlin
    ,
  • Carlos III Hospital
    ,
  • University of Munich
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 42-48 (7 pages)

Journal (Volume, Issue Number)

Diagnostic Microbiology and Infectious Disease (Volume 65, Issue 1)

Publication milestones

  • Published - 09/2009

Publication status

Published - 09/2009

ISSN

0732-8893

Publication IDs

  • Scopus: 68349104964
  • PubMed: 19679234

Abstract

A total of 520 European travelers with suspected dengue fever were examined, and acute dengue virus infection was confirmed in 127 of them. Molecular and serological tests for dengue diagnosis, according to their usefulness in the different stages of the disease, were performed. The accuracy of the IgM/IgG ratio and the IgG avidity index was confirmed during the early phase of the illness to discriminate the serologic status (primary versus secondary immune response) of patients who were either naive or previously vaccinated against other flaviviruses. Virologic markers of secondary infection were detected in 11.8% of nonvaccinated infected patients and in 92.6% of yellow fever vaccinated patients. The proper use of these simple methodologies could help in the identification of patients affected with secondary infection, who may be at a higher risk of developing a hemorrhagic disorder.

Funding Details

J. Ruiz is the recipient of a grant (CP05/0130) from Fondo de Investigaciones Sanitarias. This investigation received financial support from the Instituto de Salud Carlos III through research project grants MPY1194/02, MPY1285/06, and the Network RICET (C03/04 and RD06/0021).
FundersFunding numbers
Fondo de Investigaciones Sanitarias
-
Network RICET
C03/04, RD06/0021
ISCIII
MPY1285/06, MPY1194/02

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Mentions
1
Citations
26
Captures
59

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well